St. Gallen 2007: Breast Cancer Treatment Consensus Report

@article{Harbeck2007StG2,
  title={St. Gallen 2007: Breast Cancer Treatment Consensus Report},
  author={N. Harbeck and R. Jakesz},
  journal={Breast Care},
  year={2007},
  volume={2},
  pages={130 - 134}
}
  • N. Harbeck, R. Jakesz
  • Published 2007
  • Medicine
  • Breast Care
    • The focus of this year’s St. Gallen Consensus Conference was on providing substantial and largely evidence-based recommendations for the treatment of early breast cancer, indicating a broad spectrum of acceptable clinical practice. This report summarises the results of the 2007 international panel voting procedures with regard to endocrine treatment, chemotherapy and antibody therapy. 
    View via Publisher
    karger.com
    30 Citations
    Background Citations
    3
    Methods Citations
    3

    Figures and Topics from this paper

    Figures

    Explore Further: Topics Discussed in This Paper

    30 Citations
    Citation Type

    Citation Type

    Targeting HER2 in the adjuvant setting: dealing with new standards and with open questions.
    • 2
    Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience.
    • 11
    Evidence-Based Complementary Medicine in Breast Cancer Therapy
    • 10
    Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study.
    • 27
    The feasibility of a randomised controlled trial for the axillary management of a select group of invasive breast cancer patients: SLNB vs. no-SLNB
    • 2
    Implementation and evaluation of an Asbru-based decision support system for adjuvant treatment in breast cancer
    • 8
    Trends and Present Treatment Patterns of Early Breast Cancer in Southwest China
    • 4
    A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: Are recommendations sensitive to different global resources?
    • 7
    The follow-up of women at high risk for breast cancer relapse.
    • 1
    A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002–2010
    • 29
    • PDF

    References

    SHOWING 1-10 OF 16 REFERENCES
    First--select the target: better choice of adjuvant treatments for breast cancer patients.
    • 99
    Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.
    • 1,149
    • PDF
    Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
    • 964
    • PDF
    Application of aromatase inhibitors in endocrine responsive breast cancers.
    • 8
    Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
    • 4,493
    • PDF
    Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
    • 4,909
    • PDF
    Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
    • 253
    • PDF
    Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
    • 833
    Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.
    • 229
    Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    • 9,878
    • PDF